BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

599 related articles for article (PubMed ID: 18790859)

  • 1. The Architect Syphilis assay for antibodies to Treponema pallidum: an automated screening assay with high sensitivity in primary syphilis.
    Young H; Pryde J; Duncan L; Dave J
    Sex Transm Infect; 2009 Feb; 85(1):19-23. PubMed ID: 18790859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Qualitative and quantitative aspects of the serological diagnosis of early syphilis.
    McMillan A; Young H
    Int J STD AIDS; 2008 Sep; 19(9):620-4. PubMed ID: 18725554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The sensitivity of syphilis assays in detecting different stages of early syphilis.
    Manavi K; Young H; McMillan A
    Int J STD AIDS; 2006 Nov; 17(11):768-71. PubMed ID: 17062183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative evaluation of the INNO-LIA syphilis score and the MarDx Treponema pallidum immunoglobulin G Marblot test assays for the serological diagnosis of syphilis.
    Lam TK; Lau HY; Lee YP; Fung SM; Leung WL; Kam KM
    Int J STD AIDS; 2010 Feb; 21(2):110-3. PubMed ID: 20089996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the serodia Treponema pallidum particle agglutination, the Murex Syphilis ICE and the Enzywell TP tests for serodiagnosis of syphilis.
    Aktas G; Young H; Moyes A; Badur S
    Int J STD AIDS; 2005 Apr; 16(4):294-8. PubMed ID: 15899082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the LIAISON chemiluminescence immunoassay for diagnosis of syphilis.
    Knight CS; Crum MA; Hardy RW
    Clin Vaccine Immunol; 2007 Jun; 14(6):710-3. PubMed ID: 17460119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Consistency Between Treponema pallidum Particle Agglutination Assay and Architect Chemiluminescent Microparticle Immunoassay and Characterization of Inconsistent Samples.
    Zhiyan L; Meiling W; Ping L; Jinhua D; Zhenlin Y; Zhenru F
    J Clin Lab Anal; 2015 Jul; 29(4):281-4. PubMed ID: 24840601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of a chemiluminescent microparticle immunoassay for determination of Treponema pallidum antibodies.
    Yoshioka N; Deguchi M; Kagita M; Kita M; Watanabe M; Asari S; Iwatani Y
    Clin Lab; 2007; 53(9-12):597-603. PubMed ID: 18257467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of immunoglobulin M and G Western blot and ELISA for screening antibodies to Treponema pallidum in blood donors.
    Wang LN; Li JM
    Sex Transm Dis; 2009 Jul; 36(7):413-6. PubMed ID: 19387420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of three automated Treponema pallidum antibody assays for syphilis screening.
    Xia CS; Yue ZH; Wang H
    J Infect Chemother; 2018 Nov; 24(11):887-891. PubMed ID: 30197093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation of the anti-TP antibody latex agglutination immunoassay in routine testing and a clinical viewpoint].
    Fujimori C; Yukimasa N; Miura K; Mochizuki S; Yasuhara T; Takagi Y; Gomi K
    Rinsho Byori; 2009 Mar; 57(3):206-12. PubMed ID: 19363990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of Treponema pallidum particle agglutination assay-negative sera following screening by treponemal total antibody enzyme immunoassays.
    Maple PA; Ratcliffe D; Smit E
    Clin Vaccine Immunol; 2010 Nov; 17(11):1718-22. PubMed ID: 20844087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usefulness of IgM-specific enzyme immunoassays for serodiagnosis of syphilis: comparative evaluation of three different assays.
    Bosshard PP
    J Infect; 2013 Jul; 67(1):35-42. PubMed ID: 23542782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the fluorescent treponemal antibody absorption test for detection of antibodies (immunoglobulins G and M) to Treponema pallidum in serologic diagnosis of syphilis.
    Aktas G; Young H; Moyes A; Badur S
    Int J STD AIDS; 2007 Apr; 18(4):255-60. PubMed ID: 17509177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of two automated chemiluminescence immunoassays, the LIAISON Treponema Screen and the ARCHITECT Syphilis TP, and the Treponema pallidum particle agglutination test for laboratory diagnosis of syphilis.
    Wellinghausen N; Dietenberger H
    Clin Chem Lab Med; 2011 Aug; 49(8):1375-1377. PubMed ID: 21619473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An evaluation of the relative sensitivities of the venereal disease research laboratory test and the Treponema pallidum particle agglutination test among patients diagnosed with primary syphilis.
    Creegan L; Bauer HM; Samuel MC; Klausner J; Liska S; Bolan G
    Sex Transm Dis; 2007 Dec; 34(12):1016-1018. PubMed ID: 18080352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reactivity in the Venereal Diseases Research Laboratory test and the Mercia IgM enzyme immunoassay after treatment of early syphilis.
    McMillan A; Young H
    Int J STD AIDS; 2008 Oct; 19(10):689-93. PubMed ID: 18824622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preferable procedure for the screening of syphilis in clinical laboratories in China.
    Wang KD; Xu DJ; Su JR
    Infect Dis (Lond); 2016; 48(1):26-31. PubMed ID: 26313112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of age, gender, and pregnancy on syphilis screening using the Captia Syphilis-G assay.
    Henrich TJ; Yawetz S
    Sex Transm Dis; 2011 Dec; 38(12):1126-30. PubMed ID: 22082723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of three serological tests manufactured in Belarus for the diagnosis of syphilis.
    Shimanskaya I; Zhurauskaya L; Pankratov O; Unemo M; Ballard RC; Domeika M
    Acta Derm Venereol; 2011 May; 91(3):299-302. PubMed ID: 21369683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.